Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Cao(Shandong Provincial Hospital), Jie Xiang(Jinyintan Hospital), Hui Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiuyang Xu(Tsinghua University), Lulu Guan(Wuhan Pulmonary Hospital), Bin Song(Henan University of Science and Technology), Guohui Fan(China-Japan Friendship Hospital), Yi Zhang(Tianjin Medical University General Hospital), Ying Liu(Shanghai First Maternity and Infant Hospital), Ting Yu(Chinese Academy of Sciences), Yuan Wei(Peking University), Zhibo Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ronghui Du(Shanghai Jiao Tong University), Shengjin Tu(Jinyintan Hospital), Hua Chen(Second Military Medical University), Xudong Wu(Tianjin Medical University General Hospital)
Cited by 29,118
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k